SCHEMBL7385735

SCHEMBL7385735

[c]1cccc(-c2cccnc2)c1CN1CCC1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 2/20 0.47
▸ CHRNA4 P43681 2/20 0.47
▸ CHRNA7 P36544 2/20 0.39
▸ DHPS P49366 2/20 0.39
▸ ROCK2 O75116 1/20 0.38
▸ ROCK1 Q13464 1/20 0.38
▸ CDC42BPB Q9Y5S2 1/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.38
▸ CYP2A6 P11509 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ PTAFR P25105 1/20 0.36
▸ WNT1 P04628 1/20 0.36
▸ CLK2 P49760 1/20 0.36
▸ CLK3 P49761 1/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ SLC2A1 P11166 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6637618 0.97 CHRNB2 (0.50) CHRNB2CHRNA4CHRNA7DHPSROCK2
SCHEMBL7391205 0.96 CHRNB2 (0.49) CHRNB2CHRNA4CHRNA7DHPSROCK2
SCHEMBL7395139 0.88 MKNK1 (0.43) CHRNB2CHRNA4DHPSALDH1A1CYP1A2
SCHEMBL6637613 0.83 CHRNB2 (0.39) CHRNB2CHRNA4ROCK2ROCK1CDC42BPB
SCHEMBL7390870 0.83 HTR7 (0.42) HRH3ALDH1A1
SCHEMBL6641151 0.80 OPRK1 (0.44) HRH3ALDH1A1
SCHEMBL7392244 0.79 CYP2D6 (0.44) HRH3ALDH1A1
SCHEMBL7392131 0.77 CYP11B1 (0.51) CYP1A2CYP3A4
SCHEMBL7393797 0.77 CYP2C19 (0.38) CHRNB2CHRNA4HRH3ALDH1A1CYP1A2
SCHEMBL8195408 0.74 CYP2A6 (0.41) CYP2A6ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1259942-A Novel guanidine mimics as factor Xa inhibitors DU PONT MERCK PHARMA (US) 2000-07-12 — — CN disclosed
US-6060491-A ANTICOAGULANTS; THROMBOEMBOLIC DISORDERS; PROPHYLAXIS DUPONT PHARMACEUTICALS (US) 2000-05-09 — — US disclosed
EP-0993448-A1 (AMIDINO)6-MEMBERED AROMATICS AS FACTOR Xa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 2000-04-19 — — EP disclosed
US-5998424-A ANTICOAGULANTS DUPONT PHARMACEUTICALS COMPANY (US) 1999-12-07 — — US disclosed
WO-1998057934-A1 (AMIDINO)6-MEMBERED AROMATICS AS FACTOR Xa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-23 — — WO disclosed
Send feedback